Andrew Ferree

1.3k total citations
20 papers, 1.1k citations indexed

About

Andrew Ferree is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Andrew Ferree has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Neurology and 7 papers in Physiology. Recurrent topics in Andrew Ferree's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (5 papers) and Pluripotent Stem Cells Research (4 papers). Andrew Ferree is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (5 papers) and Pluripotent Stem Cells Research (4 papers). Andrew Ferree collaborates with scholars based in United States, Japan and Malaysia. Andrew Ferree's co-authors include Ole Isacson, Orian S. Shirihai, Benjamin Wolozin, Maria Guillily, Anna‐Liisa Brownell, Oliver Cooper, Meixiang Yu, Rosario Sánchez‐Pernaute, Shamol Saha and Jan Pruszak and has published in prestigious journals such as Journal of Neuroscience, Neurology and Journal of Neurochemistry.

In The Last Decade

Andrew Ferree

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Ferree United States 15 579 400 354 219 188 20 1.1k
Irene Fernández‐Carasa Spain 9 380 0.7× 560 1.4× 321 0.9× 290 1.3× 193 1.0× 13 1.1k
Przemyslaw Warȩski Poland 13 508 0.9× 212 0.5× 200 0.6× 426 1.9× 91 0.5× 15 1.1k
Kateřina Venderová United States 13 438 0.8× 574 1.4× 436 1.2× 227 1.0× 172 0.9× 17 1.2k
Sudarshan Phani United States 8 428 0.7× 542 1.4× 366 1.0× 198 0.9× 261 1.4× 10 1.1k
Irina Madorsky United States 23 435 0.8× 160 0.4× 404 1.1× 147 0.7× 130 0.7× 30 1.3k
Ana Gómez Spain 15 291 0.5× 346 0.9× 309 0.9× 274 1.3× 94 0.5× 30 1.1k
Kaisa M.A. Kurkinen Finland 14 452 0.8× 415 1.0× 277 0.8× 358 1.6× 191 1.0× 19 975
Victor S. Van Laar United States 14 578 1.0× 422 1.1× 296 0.8× 216 1.0× 112 0.6× 18 1.0k
Alison Wood‐Kaczmar United Kingdom 12 523 0.9× 367 0.9× 363 1.0× 144 0.7× 112 0.6× 13 910
Julia C. Fitzgerald Germany 19 591 1.0× 270 0.7× 216 0.6× 200 0.9× 137 0.7× 30 1.0k

Countries citing papers authored by Andrew Ferree

Since Specialization
Citations

This map shows the geographic impact of Andrew Ferree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Ferree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Ferree more than expected).

Fields of papers citing papers by Andrew Ferree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Ferree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Ferree. The network helps show where Andrew Ferree may publish in the future.

Co-authorship network of co-authors of Andrew Ferree

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Ferree. A scholar is included among the top collaborators of Andrew Ferree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Ferree. Andrew Ferree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferree, Andrew, et al.. (2021). Irreversible Cerebellar Ataxia Following Treatment with 5-Fluorouracil (2472). Neurology. 96(15_supplement).
2.
Ferree, Andrew. (2019). Cathepsin Oxidation Alters Alpha-Synuclein Processing. Frontiers in Neurology. 10. 530–530. 6 indexed citations
3.
Ferree, Andrew, et al.. (2017). Cefepime induced neurotoxicity: A case series and review of the literature. eNeurologicalSci. 8. 40–43. 14 indexed citations
4.
Ferree, Andrew, et al.. (2016). Cefepime Induced Neurotoxicity: A Case Series and Review of the Literature (P3.385). Neurology. 86(16_supplement).
5.
Madhusudhan, Divya, Andrew Ferree, Janice Weinberg, et al.. (2016). Sleep Disturbance in Parkinson’s Disease Varies with Age of Onset and Family History. 5(4). 103–117. 1 indexed citations
6.
Ferree, Andrew, et al.. (2016). Racial Disparities in Parkinson Disease: A Systematic Review of the Literature. 5(4). 87–96. 19 indexed citations
7.
8.
Ferree, Andrew & Orian S. Shirihai. (2012). Mitochondrial Dynamics: The Intersection of Form and Function. Advances in experimental medicine and biology. 748. 13–40. 70 indexed citations
9.
Domenico, Fabio Di, Rukhsana Sultana, Andrew Ferree, et al.. (2012). Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease. Antioxidants and Redox Signaling. 17(11). 1490–1506. 46 indexed citations
10.
Wolozin, Benjamin, Christopher V. Gabel, Andrew Ferree, Maria Guillily, & Atsushi Ebata. (2011). Watching Worms Whither. Progress in molecular biology and translational science. 100. 499–514. 41 indexed citations
11.
Ferree, Andrew, Maria Guillily, Hu Li, et al.. (2011). Regulation of Physiologic Actions of LRRK2: Focus on Autophagy. Neurodegenerative Diseases. 10(1-4). 238–241. 34 indexed citations
12.
Hsu, Cindy H., Diane Chan, Elisa Greggio, et al.. (2010). MKK6 binds and regulates expression of Parkinson’s disease‐related protein LRRK2. Journal of Neurochemistry. 112(6). 1593–1604. 82 indexed citations
13.
Saha, Shamol, Maria Guillily, Andrew Ferree, et al.. (2009). LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans. Journal of Neuroscience. 29(29). 9210–9218. 187 indexed citations
14.
Wolozin, Benjamin, Shamol Saha, Maria Guillily, Andrew Ferree, & Misha M. Riley. (2008). Investigating Convergent Actions of Genes Linked to Familial Parkinson’s Disease. Neurodegenerative Diseases. 5(3-4). 182–185. 32 indexed citations
15.
16.
Hedlund, Eva, Jan Pruszak, Andrew Ferree, et al.. (2007). Title: Selection of embryonic stem cell derived eGFP+ dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. 1 indexed citations
17.
Chung, Sangmi, Byoung‐Soo Shin, Eva Hedlund, et al.. (2006). Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. Journal of Neurochemistry. 97(5). 1467–1480. 116 indexed citations
18.
Kim, Dong‐Wook, Sangmi Chung, Andrew Ferree, et al.. (2005). Stromal Cell–Derived Inducing Activity, Nurr1, and Signaling Molecules Synergistically Induce Dopaminergic Neurons from Mouse Embryonic Stem Cells. Stem Cells. 24(3). 557–567. 80 indexed citations
19.
Sánchez‐Pernaute, Rosario, Andrew Ferree, Oliver Cooper, et al.. (2004). Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.. Journal of Neuroinflammation. 1(1). 6–6. 166 indexed citations
20.
Seo, Hyemyung, Andrew Ferree, & Ole Isacson. (2002). Cortico‐hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice. European Journal of Neuroscience. 15(3). 498–506. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Fernández‐Carasa Breakdown of academic impact, for papers by Przemyslaw Warȩski Breakdown of academic impact, for papers by Kateřina Venderová Breakdown of academic impact, for papers by Sudarshan Phani Breakdown of academic impact, for papers by Irina Madorsky Breakdown of academic impact, for papers by Ana Gómez Breakdown of academic impact, for papers by Kaisa M.A. Kurkinen Breakdown of academic impact, for papers by Victor S. Van Laar Breakdown of academic impact, for papers by Alison Wood‐Kaczmar Breakdown of academic impact, for papers by Julia C. Fitzgerald
Rankless by CCL
2026